Towards harmonization of external quality assessment/proficiency testing in hemostasis

@article{Favaloro2018TowardsHO,
  title={Towards harmonization of external quality assessment/proficiency testing in hemostasis},
  author={Emmanuel J. Favaloro and Ian Jennings and John D. Olson and Elizabeth M Van Cott and Roslyn A Bonar and Robert C Gosselin and Piet Meijer},
  journal={Clinical Chemistry and Laboratory Medicine (CCLM)},
  year={2018},
  volume={57},
  pages={115 - 126}
}
Abstract Quality in diagnostic testing represents a key target of laboratory medicine, for which an assurance around the quality of testing is expected from all involved in the process. Laboratories attempt to assure the quality of their testing by various processes, but especially by performance of internal quality control and external quality assessment (EQA). This is especially true for tests of hemostasis and coagulation. EQA in general provides information on test accuracy and on… Expand
Assessing quality in the specialized hemostasis laboratory: review and critique of external quality assurance (EQA) programs in the US
TLDR
This work reviews the current EQA options in the US for specialized hemostasis laboratories to assess whether (I) they address all three phases of testing, and whether (II) the testing platforms are providing optimal assessment ofHemostasis testing. Expand
What have we learned from coagulation laboratory participation in external quality programs?
  • K. Smock, K. Moser
  • Computer Science, Medicine
  • International journal of laboratory hematology
  • 2019
TLDR
This review article aims to summarize and provide examples of some of the important lessons learned from coagulation EQA data, including issues related to non‐standardization, imprecision, and the effects of interfering substances. Expand
Ongoing improvements in laboratory performance of coagulation factors VIII and IX: recent experience from the RCPAQAP
TLDR
An ongoing improvement is identified [reduction in numbers of laboratories outside the RCPAQAP Analytical Performance Specifications (APS)] for both FVIII and FIX over this period of change in assessment criteria. Expand
Recent Advances in Mainstream Hemostasis Diagnostics and Coagulation Testing
TLDR
A snapshot of mainstream hemostasis diagnostics and coagulation testing drives positive future changes that will ultimately provide the best outcomes for laboratories performing he mostasis assays and the patients they help diagnose and manage are provided. Expand
Recent initiatives in harmonization of hemostasis practice
TLDR
This paper concentrates on some recent and important initiatives in harmonizing hemostasis practice, and various groups involved in such initiatives are highlighted. Expand
Hemostasis practice: state-of-the-art
TLDR
Albeit many supranational initiatives are underway to improve quality throughout the total hemostasis testing process, several important issues still plague this important branch of laboratory medicine, including the unacceptable heterogeneity of available diagnostic algorithms for both diagnosis and therapeutic management of hemostatic diseases, the inaccurate definition of reference ranges, the identification and communication of critical values. Expand
Clinical and laboratory diagnosis of rare coagulation disorders (RCDs).
TLDR
In addition to outlining the principles of clinical and laboratory diagnosis, this review explores molecular basis of RCDs and laboratory techniques for genetic analysis, and discusses the importance and effectiveness of quality control programs to ensure standardized laboratory results. Expand
On the complexity of hemostasis and the need for harmonization of test practice
TLDR
The modern hemostasis laboratory has an arsenal of tests it can perform for investigation of he mostasis, and laboratories can help diagnose bleeding disorders such as hemophilia or VWD, explain the occurrence of familial thrombophilia and manage patients under therapy. Expand
...
1
2
...

References

SHOWING 1-10 OF 72 REFERENCES
Lack of grading agreement among international hemostasis external quality assessment programs
  • J. Olson, I. Jennings, +14 authors I. Walker
  • Medicine
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • 2018
TLDR
All EQA programs in this study employed statistical methods compliant with the International Standardization Organization (ISO), ISO 13528, yet the evaluation of laboratory results for all four analytes showed remarkable grading discordance. Expand
Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program.
TLDR
This article reviews the published experience of the CAP proficiency testing program in hemostasis and formulates general conclusions about the benefits of EQA. Expand
Quality control in coagulation testing.
TLDR
Current available data on analytical quality in coagulation testing not only demonstrates that quality is often unsatisfactory, but also highlights the need for more objective establishment of performances goals. Expand
Proficiency testing/external quality assurance for the PFA-100®
TLDR
An EQA process for the PFA-100® has been developed that includes a highly reproducible test-challenge process, not only proving the concept is possible for platelet function testing, but also providing a valuable mechanism for monitoring and improving laboratory performance. Expand
Internal quality control and external quality assurance of platelet function tests.
  • E. Favaloro
  • Medicine
  • Seminars in thrombosis and hemostasis
  • 2009
TLDR
EQA organizations may be best placed to act as facilitators to the process of improving diagnostic testing for platelet function, which supplements the role of expert organizations. Expand
External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update.
TLDR
EQA and IQC processes for the PFA-100/PFA-200 have been developed that include highly reproducible test challenge processes, not only supporting the concept that EQA/IQC is possible for platelet function testing but also providing a valuable mechanism for monitoring and improving laboratory performance in this area. Expand
Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
TLDR
A wide variety of test practice among inhibitor testing laboratories, a wide variation in detected inhibitor levels in cross-tested samples, and substantial evidence of false-positive and false-negative detection of factor inhibitors are revealed. Expand
External quality assurance in thrombosis and hemostasis: an international perspective.
TLDR
A survey of program structure and function revealed variation in the size and structure among the EQA programs, as well as the staffing levels, which will lead to improvement of the programs. Expand
An Assessment of the State of Current Practice in Coagulation Laboratories.
TLDR
These results may help laboratories negotiate for additional technologists if needed, prepare for Ebola specimens, and manage the demand for laboratory tests for new DOAC anticoagulants. Expand
External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program.
TLDR
The results show that testing of von Willebrand factor (vWF):antigen and ristocetin cofactor activity ( vWF:RCo) is reasonably accurate, with all-method mean values falling within 3.2 and 5.6%, respectively, of the International Society on Thrombosis and Haemostasis Secondary Coagulation Standard (lot 2) assigned values. Expand
...
1
2
3
4
5
...